Stratec SE logo

Stratec SE (SBS)

Market Closed
12 Jun, 20:00
17. 42
-0.22
-1.2472%
- Market Cap
- P/E Ratio
0.3% Div Yield
600 Volume
- Eps
17.64
Previous Close
Add Transaction
Day Range
17.42 18.62
Year Range
16.3 32.95
Want to track SBS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SBS closed today lower at €17.42, a decrease of -1.2472% from yesterday's close, completing a monthly decrease of -1.8038% or -€0.32. Over the past 12 months, SBS stock lost -21.7079%.
SBS pays dividends to its shareholders, with the most recent payment made on Jul 02, 2025. The next announced payment will be in In 1 weeks on Jun 26, 2026 for a total of €0.6.
The last earnings report, released on Apr 28, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Stratec SE has completed 2 stock splits, with the recent split occurring on Jul 31, 2006.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

SBS Chart

Stratec SE (SBS) FAQ

What is the stock price today?

The current price is €17.42.

On which exchange is it traded?

Stratec SE is listed on XSTU.

What is its stock symbol?

The ticker symbol is SBS.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.3%.

What is its market cap?

As of today, no market cap data is available.

Has Stratec SE ever had a stock split?

Stratec SE had 2 splits and the recent split was on Jul 31, 2006.

Stratec SE Profile

Technology Hardware, Storage & Peripherals Industry
Information Technology Sector
Marcus Wolfinger CEO
XSTU Exchange
DE000STRA555 ISIN
DE Country
1,462 Employees
24 Jun 2026 Last Dividend
31 Jul 2006 Last Split
- IPO Date

Overview

Stratec SE is a pivotal enterprise in the global medical and diagnostic sectors, recognized for its innovative automation and instrumentation solutions. Headquartered in Birkenfeld, Germany, the company boasts an international presence, illustrating a robust commitment to advancing the fields of in-vitro diagnostics and life sciences. Founded in 1979, Stratec has undergone significant evolution, most notably transitioning from its earlier identity as STRATEC Biomedical AG to its current designation, Stratec SE, in December 2018. This rebranding underscored its expansive scope of operations, which are neatly categorized into three primary segments: Instrumentation, Diatron, and Smart Consumables, each tailored to meet specific industry demands while synergizing to reinforce Stratec's market position within Germany, the European Union, and beyond.

Products and Services

  • Instrumentation

    This segment represents the core of Stratec's operations, focusing on the design and manufacturing of automated analyzer systems. These sophisticated systems serve a vital purpose in clinical diagnostics and biotechnology, enabling efficient, accurate testing results. Alongside these systems, Stratec also offers an assortment of service parts and consumables, catering to the ongoing operational needs of their customers. This comprehensive support ensures not only the functionality of their instrumentation but also its relevancy and adaptability to advancements within the scientific community.

  • Diatron

    Specifically targeting the low throughput segment, the Diatron division provides a suite of solutions designed for efficiency and accuracy on a smaller scale. This includes a range of systems, system components, consumables, and tests, all tailored to meet the unique demands of diagnostic and research environments with lower volume requirements. Such offerings make precision diagnostics accessible to more facilities, extending the reach of advanced medical technology.

  • Smart Consumables

    The innovative edge of Stratec is most evident in its Smart Consumables segment. Here, the company leverages its expertise in diagnostics, life sciences, and medical technologies to develop and manufacture 'smart' consumables. These products are characterized by their integration of advanced materials and technologies that enhance the performance and capabilities of diagnostic and research applications. This forward-thinking approach reflects Stratec's commitment to pioneering solutions that meet the evolving needs of the healthcare and research industries.

Contact Information

Address: Gewerbestrasse 37
Phone: 49 7082 7916 0